高级检索
    李文瑜. Bevacizumab加FU/LV:有望成为转移性结直肠癌一线化疗方案[J]. 循证医学, 2003, 3(4): 221-223. DOI: 10.3969/j.issn.1671-5144.2003.04.008
    引用本文: 李文瑜. Bevacizumab加FU/LV:有望成为转移性结直肠癌一线化疗方案[J]. 循证医学, 2003, 3(4): 221-223. DOI: 10.3969/j.issn.1671-5144.2003.04.008
    shu
    Bevacizumab plus FU/LV:new first-line chemotherapy of metastatic colorectal cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(4): 221-223. DOI: 10.3969/j.issn.1671-5144.2003.04.008
    Citation: Bevacizumab plus FU/LV:new first-line chemotherapy of metastatic colorectal cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(4): 221-223. DOI: 10.3969/j.issn.1671-5144.2003.04.008
    shu

    Bevacizumab加FU/LV:有望成为转移性结直肠癌一线化疗方案

    Bevacizumab plus FU/LV:new first-line chemotherapy of metastatic colorectal cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回